Podium to Practice: EHA 2025 – Lymphoma: PHASE II RANDOMIZED CONTROLLED TRIAL CT01976182
OR
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
Speakers
Studies / Trials Discussed
S190 – CYCLOPHOSPHAMIDE IS SUPERIOR TO METHOTREXATE IN PREVIOUSLY UNTREATED LARGE GRANULAR LYMPHOCYTE LEUKEMIA. FINAL RESULTS OF A PROSPECTIVE, MULTICENTRIC, PHASE II RANDOMIZED CONTROLLED TRIAL CT01976182.
This program has been made possible through unrestricted support from Eli Lilly, Merck & Roche.
Studies/trials discussed:
S190 – CYCLOPHOSPHAMIDE IS SUPERIOR TO METHOTREXATE IN PREVIOUSLY UNTREATED LARGE GRANULAR LYMPHOCYTE LEUKEMIA. FINAL RESULTS OF A PROSPECTIVE, MULTICENTRIC, PHASE II RANDOMIZED CONTROLLED TRIAL CT01976182.
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.